Cargando…
Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India
BACKGROUND & OBJECTIVES: The increasing prevalence of extended-spectrum β-lactamases (ESBLs) has abated therapeutic options worldwide. This study was undertaken to investigate the molecular profile and resistance patterns of ESBLs among clinical isolates of Escherichia coli and Klebsiella pneumo...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563744/ https://www.ncbi.nlm.nih.gov/pubmed/31219085 http://dx.doi.org/10.4103/ijmr.IJMR_172_18 |
_version_ | 1783426601984196608 |
---|---|
author | Gautam, Vikas Thakur, Anjana Sharma, Megha Singh, Avinash Bansal, Shruti Sharma, Aditi Kapil, Arti Das, Bimal Kumar Sistla, Sujatha Parija, Subhash Chandra Veeraraghavan, Balaji Prakash, John Antony Jude Walia, Kamini Ohri, V.C. Ray, Pallab |
author_facet | Gautam, Vikas Thakur, Anjana Sharma, Megha Singh, Avinash Bansal, Shruti Sharma, Aditi Kapil, Arti Das, Bimal Kumar Sistla, Sujatha Parija, Subhash Chandra Veeraraghavan, Balaji Prakash, John Antony Jude Walia, Kamini Ohri, V.C. Ray, Pallab |
author_sort | Gautam, Vikas |
collection | PubMed |
description | BACKGROUND & OBJECTIVES: The increasing prevalence of extended-spectrum β-lactamases (ESBLs) has abated therapeutic options worldwide. This study was undertaken to investigate the molecular profile and resistance patterns of ESBLs among clinical isolates of Escherichia coli and Klebsiella pneumoniae at four tertiary care centres in India. METHODS: Clinical isolates of E. coli and K. pneumoniae were collected from the All India Institute of Medical Sciences (AIIMS), New Delhi; the Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Puducherry; Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh and Christian Medical College (CMC), Vellore, over one and a half year period. Antimicrobial susceptibility was determined by Kirby-Bauer disc diffusion method. ESBLs were confirmed phenotypically, and multiplex PCR was performed to identify genes for β-lactamases (bla(TEM), bla(SHV), bla(OXA-1), bla(CTXM-1), bla(CTXM-2), bla(CTXM-9) and bla(CTXM-15)). RESULTS: Among 341 E. coli isolates collected during the study period, 171 (50%) harboured bla(TEM), 145 (43%) bla(OXA-1), 70 (21%) bla(CTXM-1), 19 (6%) bla(SHV) and four (1%) harboured bla(CTXM-2). Phenotypically, combined disc test detected ESBL production in 98/298 (33%) E. coli. Among 304 K. pneumoniae isolates, 115 (38%), 89 (29%), 83 (27%), 64 (21%) and two (0.6%) harboured bla(TEM), bla(OXA-1), bla(CTXM-1), bla(SHV) and bla(CTXM-2), respectively. Combined disc test (CDT) detected ESBL production in 42 per cent K. pneumoniae. Most of the bla(CTXM-1) positive isolates were also bla(CTXM-15) positive. The carbapenem susceptibility ranged from 56 to 88 per cent for E. coli and from 20 to 61 per cent for K. pneumoniae. Antibiotic sensitivity patterns showed that colistin (CST) was the most sensitive drug for both E. coli (271/274, 99%) and K. pneumoniae (229/234, 98%). INTERPRETATION & CONCLUSIONS: The prevalence of ESBL among four study centres varied, and bla(TEM,) bla(OXA-1) and bla(CTXM-15) were the most common genotypes in E. coli and K. pneumoniae isolates in India. The growing carbapenem resistance and emerging colistin resistance warrant the judicious use of these antimicrobials. |
format | Online Article Text |
id | pubmed-6563744 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-65637442019-06-14 Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India Gautam, Vikas Thakur, Anjana Sharma, Megha Singh, Avinash Bansal, Shruti Sharma, Aditi Kapil, Arti Das, Bimal Kumar Sistla, Sujatha Parija, Subhash Chandra Veeraraghavan, Balaji Prakash, John Antony Jude Walia, Kamini Ohri, V.C. Ray, Pallab Indian J Med Res Original Article BACKGROUND & OBJECTIVES: The increasing prevalence of extended-spectrum β-lactamases (ESBLs) has abated therapeutic options worldwide. This study was undertaken to investigate the molecular profile and resistance patterns of ESBLs among clinical isolates of Escherichia coli and Klebsiella pneumoniae at four tertiary care centres in India. METHODS: Clinical isolates of E. coli and K. pneumoniae were collected from the All India Institute of Medical Sciences (AIIMS), New Delhi; the Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Puducherry; Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh and Christian Medical College (CMC), Vellore, over one and a half year period. Antimicrobial susceptibility was determined by Kirby-Bauer disc diffusion method. ESBLs were confirmed phenotypically, and multiplex PCR was performed to identify genes for β-lactamases (bla(TEM), bla(SHV), bla(OXA-1), bla(CTXM-1), bla(CTXM-2), bla(CTXM-9) and bla(CTXM-15)). RESULTS: Among 341 E. coli isolates collected during the study period, 171 (50%) harboured bla(TEM), 145 (43%) bla(OXA-1), 70 (21%) bla(CTXM-1), 19 (6%) bla(SHV) and four (1%) harboured bla(CTXM-2). Phenotypically, combined disc test detected ESBL production in 98/298 (33%) E. coli. Among 304 K. pneumoniae isolates, 115 (38%), 89 (29%), 83 (27%), 64 (21%) and two (0.6%) harboured bla(TEM), bla(OXA-1), bla(CTXM-1), bla(SHV) and bla(CTXM-2), respectively. Combined disc test (CDT) detected ESBL production in 42 per cent K. pneumoniae. Most of the bla(CTXM-1) positive isolates were also bla(CTXM-15) positive. The carbapenem susceptibility ranged from 56 to 88 per cent for E. coli and from 20 to 61 per cent for K. pneumoniae. Antibiotic sensitivity patterns showed that colistin (CST) was the most sensitive drug for both E. coli (271/274, 99%) and K. pneumoniae (229/234, 98%). INTERPRETATION & CONCLUSIONS: The prevalence of ESBL among four study centres varied, and bla(TEM,) bla(OXA-1) and bla(CTXM-15) were the most common genotypes in E. coli and K. pneumoniae isolates in India. The growing carbapenem resistance and emerging colistin resistance warrant the judicious use of these antimicrobials. Wolters Kluwer - Medknow 2019-02 /pmc/articles/PMC6563744/ /pubmed/31219085 http://dx.doi.org/10.4103/ijmr.IJMR_172_18 Text en Copyright: © 2019 Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Gautam, Vikas Thakur, Anjana Sharma, Megha Singh, Avinash Bansal, Shruti Sharma, Aditi Kapil, Arti Das, Bimal Kumar Sistla, Sujatha Parija, Subhash Chandra Veeraraghavan, Balaji Prakash, John Antony Jude Walia, Kamini Ohri, V.C. Ray, Pallab Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India |
title | Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India |
title_full | Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India |
title_fullStr | Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India |
title_full_unstemmed | Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India |
title_short | Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India |
title_sort | molecular characterization of extended-spectrum β-lactamases among clinical isolates of escherichia coli & klebsiella pneumoniae: a multi-centric study from tertiary care hospitals in india |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563744/ https://www.ncbi.nlm.nih.gov/pubmed/31219085 http://dx.doi.org/10.4103/ijmr.IJMR_172_18 |
work_keys_str_mv | AT gautamvikas molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia AT thakuranjana molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia AT sharmamegha molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia AT singhavinash molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia AT bansalshruti molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia AT sharmaaditi molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia AT kapilarti molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia AT dasbimalkumar molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia AT sistlasujatha molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia AT parijasubhashchandra molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia AT veeraraghavanbalaji molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia AT prakashjohnantonyjude molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia AT waliakamini molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia AT ohrivc molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia AT raypallab molecularcharacterizationofextendedspectrumblactamasesamongclinicalisolatesofescherichiacoliklebsiellapneumoniaeamulticentricstudyfromtertiarycarehospitalsinindia |